{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-032503","form_type":"8-K","ticker":"PDSB","cik":"0001472091","company_name":"PDS Biotechnology Corp","filed_at":"2025-08-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.057531+00:00","generated_at":"2026-05-17T10:12:18.290162+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"PDS Biotechnology files routine corporate presentation update; no material new information disclosed","bullets":["Company updated its investor presentation deck on August 25, 2025 (Exhibit 99.1).","The filing contains no new financial results, clinical data, or guidance changes.","Presentation covers previously announced precision oncology pipeline, no new milestones.","No material events such as earnings, M&A, regulatory actions, or leadership changes."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-032503","json":"https://secwatch.observer/filing/0001140361-25-032503.json","markdown":"https://secwatch.observer/filing/0001140361-25-032503.md","text":"https://secwatch.observer/filing/0001140361-25-032503.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125032503/0001140361-25-032503-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125032503/ef20054434_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T10:12:18.290162+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}